23 Jan 2020
Result of General Meeting19 Aug 2019
First Cohort of Patients Successfully Dosed in RXC004 Phase 1/2 Study; Second Cohort Enrolment Has Now Begun10 Jun 2019
Short-term Debt Funding Secured03 May 2019
Update on Plans to Strengthen Balance Sheet28 Feb 2019
Issue of Warrants and Change to Lease Agreement06 Feb 2019
Redx confirms receipt of outstanding loan23 Jan 2019
Results of Annual General Meeting21 Jan 2019
Redx to resume RXC004 clinical trial programme19 Nov 2018
Redx further strengthens Management Team and Board with appointment of Dr James Mead as CFO31 Oct 2018
Notice of Results26 Oct 2018
Redx announces details from the ROCK2 inhibitor poster presented at the ASN Kidney Week 2018 in San Diego04 Sep 2018
Redx Pharma Announces Way Forward For RXC00404 Jun 2018
Directorate Update and Grant of Options30 May 2018
Interim Results Announced29 Mar 2018
RXC004 Clinical Trial Update22 Mar 2018
Redx Pharma signs option and licence agreement for its anti-infective programme with Deinove06 Nov 2017
Redx Provides a Strategic Update and Announces that Trading is to recommence in its Shares31 Aug 2017
Redx to present new scientific data at ESMO 201724 May 2017
In Administration20 Apr 2017
Appointment of Chairman30 Mar 2017
Redx Pharma awarded US$1 million grant by CARB-X03 Mar 2017
Redx to present new scientific data at AACR 201710 Nov 2016
Redx backs global AMR event25 Oct 2016
Redx to present Preclinical Data on Novel Bacterial Topoisomerase Inhibitors at ASM Microbe 2016 Conference27 Sep 2016
Discovery of breakthrough antibiotic compounds08 Sep 2016
Board and Senior Management Changes06 Sep 2016
Supply contract agreed with Quay Pharma for expected clinical trial of Porcupine inhibitor10 Jun 2016
Redx backs North of England biotech focus24 May 2016
Interim Results24 May 2016
Proof of concept with key oncology lead09 May 2016
Board appointment14 Apr 2016
Redx Pharma Plc set for new HQ at Alderley Park12 Apr 2016
Redx backs key AMR conference24 Mar 2016
Placing to Raise £10 Million26 Feb 2016
Redx honoured at Institute of Directors Awards03 Feb 2016
World Cancer Day 201601 Jan 2016
Appointment of Non-Executive Director10 Nov 2015
BioInfect Conference – Redx joins industry leaders to combat one of the biggest threats to global health05 Nov 2015
Senior management appointments01 Oct 2015
Year-end trading update13 Jul 2015
Chancellor visits Redx labs07 Jul 2015
LSE visit to Alderley Park site02 Jun 2015
Discovery of breakthrough MRSA compound26 May 2015
Redx announces second drug development candidate11 Dec 2014
Redx features at key AMR Review18 Nov 2014
European Antibiotic Awareness Day 201412 Sep 2014
Redx Pharma strengthens senior team03 Sep 2014
Redx Pharma and AstraZeneca agree research collaboration targeting genetic drivers of tumour growth01 Sep 2014
Redx Pharma appoints new chairman20 Jun 2014
International Festival For Business 201426 Nov 2013
Redx Pharma co-sponsors BioInfect 201307 Nov 2013
Redx agrees pioneering MRSA deal with NHS11 Oct 2013
Redx CEO scoops business leadership award12 Jul 2013
RGF backing for proposed Redx Metabolic venture14 Jun 2013
Knowledge Business of the Year 2013Redx will have attendees at the following conferences:
10/03/2019
to 15/03/2019
Location: Whistler Conference Centre, Whistler, British Columbia, Canada
25/03/2019
to 27/03/2019
Location: Messe Wien Exhibition and Congress Center, Vienna, Austria
29/03/2019
to 03/04/2019
Location: Georgia World Congress Center Atlanta, Georgia, USA
30/04/2019
to 01/05/2019
Location: etc.venues 155 Bishopsgate, London, UK
17/05/2019
to 22/05/2019
Location: Dallas, Texas, US
31/05/2019
to 04/06/2019
Location: McCormick Place, Chicago, Illinois, US
03/06/2019
to 06/06/2019
Location: Philadelphia, PA, US
22/06/2019
to 25/06/2019
Location: Hilton Boston Logan Airport, Boston, US
24/06/2019
to 25/06/2019
Location: Chesham, UK
24/06/2019
to 25/06/2019
Location: Boston, US
11 Jul 2019
Video interview with Lisa Anson following sale of pan-RAF inhibitor programme to Jazz Pharmaceuticals22 Jan 2019
Redx Pharma receives approval to re-commence clinical trial of RXC004 (Proactiveinvestors.co.uk)29 Oct 2018
Redx Pharma chief elected to industry body role